title: Effect of applying the new Clinical and Laboratory Standards Institute ceftazidime and ceftriaxone susceptibility breakpoints for Escherichia coli in Hong Kong.
authors.forename: Pak-Leung
authors.initials: PL
authors.lastname: Ho
authors.forename: Kin-Hung
authors.initials: KH
authors.lastname: Chow
authors.forename: Wai-U
authors.initials: WU
authors.lastname: Lo
authors.forename: Kelvin K
authors.initials: KK
authors.lastname: To
authors.forename: Vincent C
authors.initials: VC
authors.lastname: Cheng
mesh_terms: D002442:Ceftazidime / Q000097:blood / Q000494:pharmacology* / Q000652:urine; D002443:Ceftriaxone / Q000097:blood / Q000494:pharmacology* / Q000652:urine; D004926:Escherichia coli / Q000187:drug effects* / Q000201:enzymology / Q000302:isolation & purification; D006723:Hong Kong; D006801:Humans; D008826:Microbial Sensitivity Tests; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000378:metabolism
chemical_list: D002443:Ceftriaxone; D002442:Ceftazidime; C055184:beta-lactamase TEM-3; D001618:beta-Lactamases